Literature DB >> 7653283

Cerebral toxoplasmosis after renal transplantation. Case report and review.

S Da Cunha1, E Ferreira, I Ramos, R Martins, L De Freitas, J L Borges, R Côrte-Real, A Mota, A Meliço-Silvestre, A L Furtado.   

Abstract

Infection caused by Toxoplasma gondii is a frequent event in Portugal. When this occurs in immunocompetent individuals, it is rarely a matter of concern; the contrary occurs with immunosuppressed patients or in pregnancy. Transplant patients are treated with immunosuppressive drugs which mainly disturb their mechanisms of cellular immunity, and that opens the way to infections by opportunistic intracellular microorganisms. We recently treated a renal transplant patient who suffered from cerebral toxoplasmosis, and this provided an opportunity for a review of the other 20 patients reported in medical literature to date.

Entities:  

Mesh:

Year:  1994        PMID: 7653283

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  10 in total

1.  EARLY DIAGNOSIS IN POST RENAL TRANSPLANT OPPORTUNISTIC INFECTIONS: A FRESH LOOK.

Authors:  G S Chopra; A S Narula; P S Reddy; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  A review on inactivation methods of Toxoplasma gondii in foods.

Authors:  Adel Mirza Alizadeh; Sahar Jazaeri; Bahar Shemshadi; Fataneh Hashempour-Baltork; Zahra Sarlak; Zahra Pilevar; Hedayat Hosseini
Journal:  Pathog Glob Health       Date:  2018-10-22       Impact factor: 2.894

4.  Toxoplasmosis after renal transplantation: implications of a missed diagnosis.

Authors:  M W H Wulf; R van Crevel; R Portier; C G Ter Meulen; W J G Melchers; A van der Ven; J M D Galama
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host.

Authors:  Martina Novotná; Jitka Hanusova; Jirí Klose; Marek Preiss; Jan Havlicek; Katerina Roubalová; Jaroslav Flegr
Journal:  BMC Infect Dis       Date:  2005-07-06       Impact factor: 3.090

6.  Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient.

Authors:  Lina Savsek; Tanja Ros Opaskar
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

7.  Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis.

Authors:  Ze-Dong Wang; Huan-Huan Liu; Zhan-Xi Ma; Hong-Yu Ma; Zhong-Yu Li; Zhi-Bin Yang; Xing-Quan Zhu; Bin Xu; Feng Wei; Quan Liu
Journal:  Front Microbiol       Date:  2017-03-09       Impact factor: 5.640

8.  Toxoplasmosis an Overlooked Disease: Seroprevalence in Cancer Patients

Authors:  Raafat Abdel Malek; Rita Wassef; Enas Rizk; Hoda Sabry; Nevine Tadros; Abdallah Boghdady
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27

9.  Delayed Cerebral Toxoplasmosis in a Kidney Transplant Patient: a Case Report.

Authors:  Hosung Myeong; Moowan Park; Ji Eun Kim; Sun Won Park; Sang Hyung Lee
Journal:  Korean J Parasitol       Date:  2022-02-23       Impact factor: 1.341

10.  Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.

Authors:  Lidia Węglińska; Adrian Bekier; Nazar Trotsko; Barbara Kaproń; Tomasz Plech; Katarzyna Dzitko; Agata Paneth
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.